# SCI Pharmtech Inc., Taoyuan City, Taiwan – FDA Inspections

Source: https://www.keypedia.com/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db

> Inspection records and compliance data for SCI Pharmtech Inc. in Taoyuan City. 5 FDA inspections on record, 2 Form 483s, last inspected June 06, 2025.

---

## Details

- Name: SCI Pharmtech Inc.
- FEI Number: 3004065859
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: Luzhu Dist. 309, No. 61 Ln.; Haihu N. Rd.
- City: Taoyuan City
- Country Name: Taiwan
- Address: Luzhu Dist. 309, No. 61 Ln.; Haihu N. Rd., Taoyuan City, Taiwan
- Country: Taiwan

## Related Documents

- [483 - SCI Pharmtech Inc. - 2025-06-06](https://www.keypedia.com/records/483/sci-pharmtech-inc/ad8a9849-6618-43b2-ada7-5addfaf165da) — source: FDA, date: June 6, 2025
- [FDA Inspection 1274464 - SCI Pharmtech Inc. - 2025-06-06](https://www.keypedia.com/records/fda_inspections/sci-pharmtech-inc/dd9abc18-d7ee-418e-a605-efce30c5189d) — source: FDA, date: June 6, 2025
- FDA Inspection 1274464 - SCI Pharmtech Inc. - 2025-06-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2025
- FDA Inspection 1106854 - SCI Pharmtech Inc. - 2019-09-05 — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2019
- [FDA Inspection 1028693 - SCI Pharmtech Inc. - 2017-09-15](https://www.keypedia.com/records/fda_inspections/sci-pharmtech-inc/fc1f0e1b-6497-4bfd-ada4-531c71e4de0e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2017
- FDA Inspection 908076 - SCI Pharmtech Inc. - 2014-12-19 — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2014
- FDA Inspection 783663 - SCI Pharmtech Inc. - 2012-04-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2012

## Related Companies

- [Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.](https://www.keypedia.com/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11)
- [Janssen Sciences Ireland UC](https://www.keypedia.com/companies/janssen-sciences-ireland-uc/dcb988ee-73e6-4408-afcd-1a6730ea40b1)
- [Olon SPA](https://www.keypedia.com/companies/olon-spa/7df58e77-f9cb-4929-8d1b-0f9a728b86cf)
- [Signa S.A. de C.V.](https://www.keypedia.com/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)
- [Kyongbo Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/fc196e7f-0f5e-4ef1-afa6-3023ca6df1f3)
- [Concord Biotech Limited](https://www.keypedia.com/companies/concord-biotech-limited/84ea17c0-5c3b-40cc-9098-13c3031fe2dc)
- [Merck Serono SA (Vevey)](https://www.keypedia.com/companies/merck-serono-sa-vevey/e86df39a-6cb6-4ab2-a811-47c8369ba270)
- [Unichem Laboratories Limited](https://www.keypedia.com/companies/unichem-laboratories-limited/322f49bb-81cf-4701-894c-ef740996d76b)
- [Partner Therapeutics Inc](https://www.keypedia.com/companies/partner-therapeutics-inc/837081c1-0ffa-4c06-94c1-4ce65e130882)

## Related Officers

- [Nicholas J. Presto](https://www.keypedia.com/people/nicholas-j-presto/2ecdd573-6662-4d07-b93c-ddb9c603bcfa)
